Radioreceptor binding profile of the atypical antipsychotic olanzapine.

Article Details

Citation

Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

Neuropsychopharmacology. 1996 Feb;14(2):87-96.

PubMed ID
8822531 [ View in PubMed
]
Abstract

The affinities of olanzapine, clozapine, haloperidol, and four potential antipsychotics were compared on binding to the neuronal receptors of a number of neurotransmitters. In both rat tissues and cell lines transfected with human receptors olanzapine had high affinity for dopamine D1, D2, D4, serotonin (5HT)2A, 5HT2C, 5HT3, alpha 1-adrenergic, histamine H1, and five muscarinic receptor subtypes. Olanzapine had lower affinity for alpha 2-adrenergic receptors and relatively low affinity for 5HT1 subtypes, GABAA, beta-adrenergic receptors, and benzodiazepine binding sites. The receptor binding affinities for olanzapine was quite similar in tissues from rat and human brain. The binding profile of olanzapine was comparable to the atypical antipsychotic clozapine, while the binding profiles for haloperidol, resperidone, remoxipride, Org 5222, and seroquel were substantially different from that of clozapine. The receptor binding profile of olanzapine is consistent with the antidopaminergic, antiserotonergic, and antimuscarinic activity observed in animal models and predicts atypical antipsychotic activity in man.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
OlanzapineBeta adrenergic receptor (Protein Group)Protein groupHumans
No
Inhibitor
Details
Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
Clozapine5-hydroxytryptamine receptor 2CKi (nM)8N/AN/ADetails
ClozapineMuscarinic acetylcholine receptor M1Ki (nM)1.4N/AN/ADetails
ClozapineMuscarinic acetylcholine receptor M3Ki (nM)7N/AN/ADetails
ClozapineMuscarinic acetylcholine receptor M4Ki (nM)6N/AN/ADetails
Olanzapine5-hydroxytryptamine receptor 2AKi (nM)7N/AN/ADetails
Olanzapine5-hydroxytryptamine receptor 2CKi (nM)11N/AN/ADetails
Olanzapine5-hydroxytryptamine receptor 2CKi (nM)71N/AN/ADetails
OlanzapineDopamine D1 receptorKi (nM)25N/AN/ADetails
OlanzapineMuscarinic acetylcholine receptor M1Ki (nM)2.5N/AN/ADetails
OlanzapineMuscarinic acetylcholine receptor M1Ki (nM)2N/AN/ADetails
OlanzapineMuscarinic acetylcholine receptor M3Ki (nM)13N/AN/ADetails
OlanzapineMuscarinic acetylcholine receptor M4Ki (nM)10N/AN/ADetails
Quetiapine5-hydroxytryptamine receptor 2CKi (nM)615N/AN/ADetails
QuetiapineMuscarinic acetylcholine receptor M1Ki (nM)135N/AN/ADetails
QuetiapineMuscarinic acetylcholine receptor M3Ki (nM)705N/AN/ADetails
QuetiapineMuscarinic acetylcholine receptor M4Ki (nM)225N/AN/ADetails